Aspiriant LLC’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History
Bought
Maintained
Sold
Other funds holding BIV
BCMIO
DDSF
SB
Aspiriant LLC's BIV Position: Q4 2017 in Review
Aspiriant LLC sold out of Vanguard Intermediate-Term Bond ETF (BIV) in Q4 2017, closing a stake of 4,050 shares — an estimated $343K sold.
Aspiriant LLC first reported a position in BIV in Q3 2017 and held it in 1 quarter. The position peaked at $343K in Q3 2017. 406 funds tracked by Wall St. Rank hold BIV as of Q4 2017.
- Aspiriant LLC reported no remaining Vanguard Intermediate-Term Bond ETF position as of Q4 2017 after selling out during the quarter.
- Aspiriant LLC sold 4,050 Vanguard Intermediate-Term Bond ETF shares in Q4 2017, an estimated $343K.
- Aspiriant LLC first reported a position in Vanguard Intermediate-Term Bond ETF in Q3 2017 and held it in 1 quarter.
- Aspiriant LLC's Vanguard Intermediate-Term Bond ETF position peaked at $343K in Q3 2017.
- 406 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q4 2017.
Based on Aspiriant LLC's 13F filing for Q4 2017, filed 31 Jan 2018.